AngioDynamics Reports Fiscal 2018 First Quarter Results
September 28, 2017 06:00 ET | AngioDynamics
Q1 net sales of $85.4 million, down 3% year-over-year             Q1 GAAP earnings per share of $0.00; adjusted EPS of $0.12Q1 operating cash generation of $3.0 million; free cash flow generation of...
Outcomes in a Nurse-Led Peripherally Inserted Central Catheter Program: A Retrospective Cohort Study Published in CMAJ Open
September 14, 2017 07:00 ET | AngioDynamics
Low rates of major PICC-associated complications attributed in-part to the novel BioFlo catheter material Data to be presented at AngioDynamics-sponsored symposium at the annual scientific meeting of...
AngioDynamics to Report Fiscal 2018 First Quarter Financial Results
September 14, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., Sept. 14, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference
September 13, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., Sept. 13, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Morgan Stanley Global Healthcare Conference
August 29, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., Aug. 29, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics to Present at the 2017 Canaccord Genuity Growth Conference
August 07, 2017 07:48 ET | AngioDynamics
ALBANY, N.Y., Aug. 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
July 18, 2017 06:00 ET | AngioDynamics
Company posts record full-year adjusted EPS and Free Cash Flow and issues FY2018 Financial Guidance Q4 net sales of $86.9 million, down 7% year-over-yearQ4 GAAP loss per share of $0.30; adjusted EPS...
AngioDynamics to Report Fiscal 2017 Fourth Quarter and Full-Year Financial Results
July 07, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., July 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular...
AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
June 07, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., June 07, 2017 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease and...
AngioDynamics Lawsuit Alleges C.R. Bard is Violating Antitrust Laws, Harming Competition and Limiting Access
May 31, 2017 06:00 ET | AngioDynamics
ALBANY, N.Y., May 31, 2017 (GLOBE NEWSWIRE) -- C.R. Bard has illegally tied the sale of its tip location systems to its line of peripherally inserted central catheters (“PICCs”), violating federal...